These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 11476896
1. Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells. Takahashi SI, Nedachi T, Fukushima T, Umesaki K, Ito Y, Hakuno F, Van Wyk JJ, Conti M. Biochim Biophys Acta; 2001 Jul 25; 1540(1):68-81. PubMed ID: 11476896 [Abstract] [Full Text] [Related]
2. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. Sette C, Iona S, Conti M. J Biol Chem; 1994 Mar 25; 269(12):9245-52. PubMed ID: 8132662 [Abstract] [Full Text] [Related]
3. Repeatedly passed FRTL-5 rat thyroid cells can develop insulin and insulin-like growth factor-I-sensitive cyclooxygenase and prostaglandin E2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA. Bellur S, Tahara K, Saji M, Grollman EF, Kohn LD. Endocrinology; 1990 Sep 25; 127(3):1526-40. PubMed ID: 2167218 [Abstract] [Full Text] [Related]
9. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Erdogan S, Houslay MD. Biochem J; 1997 Jan 01; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416 [Abstract] [Full Text] [Related]
10. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S. Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [Abstract] [Full Text] [Related]
11. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Yamamoto K, Hirai A, Ban T, Saito J, Tahara K, Terano T, Tamura Y, Saito Y, Kitagawa M. Endocrinology; 1996 May 01; 137(5):2036-42. PubMed ID: 8612545 [Abstract] [Full Text] [Related]
12. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells. Mori K, Stone S, Braverman LE, DeVito WJ. Endocrinology; 1996 Nov 01; 137(11):4994-9. PubMed ID: 8895373 [Abstract] [Full Text] [Related]